Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Cleaning Validation Studies for Multi-Purpose Facility : Vial Filling Machine

다품목 공용 제약설비인 바이알 충전기에 대한 세척공정 밸리데이션

  • Published : 2009.08.20
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study is to evaluate the efficacy of stipulated cleaning process, and the prohibition of cross-contamination and microbiological contamination, which inadequate cleaning in multi-production could occur, through cleaning validation of multi-purpose facility used to produce five biopharmaceutical products as sterile injection. After production of five biopharmaceutical products such as hGH, rhGCSF, rhEPO, rhFSH and rhIFN using vial filling machine, the cleaning validation such as residual analysis of active ingredients or human serum albumin, measurement of total organic carbon (TOC), residual analysis of detergent and microbiological contamination were carried out. In the case of rhGH and rhGCSF clean validations, drug residues were not detected. Furthermore, in the case of rhEPO, rhFSH and rhIFN clean validations, human serum albumin residues were not detected. At TOC (total organic carbon) analysis, all clean validations gave the TOC of about average 137.93%, not more than 150% of acceptance criteria. At sodium analysis for the checking of residues of cleaning agent, sodium residues were not detected. In sterility test, they showed no microbiological contamination of bacteria and fungi. Thus, this cleaning validation was determined as successful in protection of cross-contamination and induction of safety in multi-purpose facility.

Keywords

References

  1. J. Agalloco, Points to Consider in the Validation of Equipment Cleaning Procedures, PDA J. Paren. Sci. Technol., 46 (5), 163-168 (1992)
  2. R. Sharnez, J. Lathia, D. Kahlenberg and S. Prabhu, M. Dekleva, In situ monitoring of soil dissolution dynamics: a rapid and simple method for determining worst-case soils for cleaning validation, PDA J. Pharm. Sci. Technol., 58 (4), 203-214 (2004).
  3. K.M., Jenkins and A.J. Vanderwielen, 1994. Cleaning Validation : An Overall Perspective, Pharmaceutical Technology, 18 (4), 60-73
  4. 식품의약품안전청 고시 제2008-5호 (2008.1.16), 의약품등 밸리데이션 실시에 관한 규정 (2008).
  5. W. Resto, D. Hernandez, R. Rey, H. Colon and J. Zayas, Cleaning validation 2: development and validation of an ion chromatographic method for the detection of traces of CIP- 100 detergent, J. Pharm. Biomed. Anal., 44 (1), 265-269 (2007). https://doi.org/10.1016/j.jpba.2007.01.037
  6. G.L. Fourman and M.V. Mullen, Determining Cleaning Validation Acceptance Limits for Pharmaceutical Manufacturing Operations, Pharmaceutical Technology International, 17 (4), 46-60 (1993).
  7. C. Glover, Validation of the total organic carbon (TOC) swab sampling and test method, PDA J. Pharm. Sci. Technol., 60 (5), 284-290 (2006).
  8. D. Loutradis, P. Drakakis, A. Vlismas and A. Antsaklis, Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility, Curr. Opin. Investig. Drugs, 10 (4), 372-380 (2009).
  9. N. Kubota, Orita, T. and K. Hattori, Structural characterization of natural and recombinant human granulocyte colonystimulating factors, J. Biochem., 107 (3), 486-492 (1990). https://doi.org/10.1093/oxfordjournals.jbchem.a123072
  10. J.L. Mehta, Erythropoietin in cardioprotection: does it have a future or is it all in the past? Cardiovasc. Res., 79 (4), 549- 50 (2008). https://doi.org/10.1093/cvr/cvn176
  11. I. Lugan, S. Febbraro, H. Lecuelle, O. Papasouliotis, Q. Ho-Nguyena and M. Buraglio, Bioequivalence of liquid and freeze-dried recombinant human follicle-stimulating hormone, Curr. Med. Res. Opin., 21 (1), 121-125 (2005). https://doi.org/10.1185/030079904X18027
  12. L.G. De Leede, J.E. Humphries, A.C. Bechet, E.J. Van Hoogdalem, R. Verrijk and D.G. Spencer, Novel controlledrelease Lemna-derived IFN-alpha2b(Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial, J. Interferon Cytokine Res., 28 (2), 113-122 (2008). https://doi.org/10.1089/jir.2007.0073
  13. LeBlanc, D.A., Rinse Sampling for Cleaning Validation Studies, Pharmaceutical Technology, 22 (5), 66-74 (1998).
  14. R. Turci and C. Minoia, Residual hazard assessment related to handling of antineoplastic drugs: safety system evolution and quality assurance of analytical measurement, Ann. N. Y. Acad. Sci., 1076, 649-656 (2006). https://doi.org/10.1196/annals.1371.047
  15. H.J. Kim, C.H. Shin and C.W. Kim, Stabilization of glycoprotein liquid formulation using arginine: a study with lactoferrin as a model protein, Biosci. Biotechnol. Biochem. 73 (1), 61-66 (2009). https://doi.org/10.1271/bbb.80475
  16. S. Rzepka, B. Neidhart, Transport processes through tracketch membrane filters in a reagent delivery cell, Fresenius J. Anal. Chem., 366 (4), 336-340 (2000). https://doi.org/10.1007/s002160050068
  17. E.C. Tidswell, Bacterial adhesion: considerations within a risk-based approach to cleaning validation, PDA J. Pharm. Sci. Technol., 59 (1), 10-32 (2005).